TenX plans to consult both the FDA and EMA regarding the results of its clinical trials.
1 report, 1 independent
Updated Aug 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TenX plans to consult both the FDA and EMA regarding the results of its clinical trials.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TenX
A human centered design and technology studio.
-
EMA
Japanese vocalist of the group DUSTCELL
Nothing else this week.
- FDA
Related events
- Omeros Corporation's drug received FDA approval and is currently undergoing review by the European Medicines Agency.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- Litigation regarding FDA approval process.
- Adam Craig reported positive results that could support FDA approval for a treatment.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.